Sentinel Diagnostics will be among the key participants at GISCoR 2025, the 18th National Congress of the Italian Group for Colorectal Cancer Screening, taking place on November 6–7, 2025, at the T Hotel in Cagliari.
The congress is one of the most important national events for professionals involved in the prevention and early diagnosis of colorectal cancer, offering a high-level exchange among experts, researchers, and healthcare professionals from all over Italy.
Congress Focus: Centralization, Quality, and Innovation in FIT
The 2025 edition of GISCoR will place particular emphasis on the FIT (Fecal Immunochemical Test), exploring the challenges and opportunities related to the centralization of screening processes, the quality of samples and analyses, and the evolution toward increasingly personalized and integrated screening models.
Topics will also include strategies to increase participation in prevention programs, the expansion of target age groups, and technological innovations that are redefining early colorectal cancer diagnosis.
📍 Where to find us
Stand 6 – T Hotel, Cagliari
The Sentinel team will be present to showcase its advanced solutions for gastrointestinal diagnostics and to engage with healthcare professionals on the new perspectives of prevention.
Sentinel solutions for gastrointestinal diagnostics
During GISCoR 2025, Sentinel Diagnostics will present a comprehensive portfolio of gastrointestinal diagnostic solutions on a single platform, with a focus on the prevention and monitoring of major digestive tract disorders.
1. FOB Gold® – The Benchmark for Colorectal Screening (FIT)
At the core of Sentinel’s cancer prevention offering, FOB Gold® is a quantitative immunochemical test for the detection of fecal occult blood (FIT), widely adopted in national and international screening programs.
Thanks to its high sensitivity, automation, and traceability, it supports laboratories in the efficient and standardized management of screening workflows.
2. CALiaGold® – Fecal Calprotectin for IBD
A quantitative test for the determination of fecal calprotectin, a key biomarker in the diagnosis and monitoring of inflammatory bowel diseases (IBD).
CALiaGold® enables fast and accurate differentiation between functional and inflammatory intestinal disorders.
3. PYLiaGold® – Detection of Helicobacter pylori
A reliable solution for the semi-quantitative determination of Helicobacter pylori antigen in stool samples, useful for both diagnosis and follow-up of gastric infections.
PYLiaGold® ensures speed, hygiene, and automation of the analytical process.
4. PRIMA Professional Rapid Tests
The PRIMA Professional line complements Sentinel’s offering with lateral flow tests designed for immediate screening and diagnostic support in clinical and laboratory settings:
- Bowel FOB Rapid Test – for the qualitative detection of fecal occult blood
- Helicobacter pylori Antigen Rapid Test – for the rapid identification of H. pylori antigen
A continuous commitment to prevention
Through its participation in GISCoR 2025, Sentinel Diagnostics reaffirms its commitment to developing next-generation diagnostic solutions for gastroenterology, providing reliable and innovative tools that support prevention, early diagnosis, and improved patient quality of life.
📍 We look forward to seeing you in Cagliari, on November 6–7, 2025 – Stand 6, to explore our gastrointestinal diagnostic solutions and discuss together the future of colorectal cancer screening.